Literature DB >> 16604826

Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation.

V Atay1, C Cam, M Muhcu, M Cam, A Karateke.   

Abstract

Letrozole was compared with clomiphene citrate (CC) as a first-line treatment for ovulation induction in women with polycystic ovaries (PCOs). A total of 106 women with primary infertility and a diagnosis of PCOs were randomized to receive either 100 mg CC (n = 55) or 2.5 mg letrozole (n = 51) daily for 5 days. Human chorionic gonadotrophin (hCG) at a dose of 10000 IU was administered when at least one follicle with a mean diameter > or = 18 mm was observed using transvaginal ultrasound. The number of mature follicles was significantly lower, but endometrial thickness and ovulation and pregnancy rates were significantly higher in the letrozole group than in the CC group. In conclusion, letrozole is associated with a higher pregnancy rate than CC in PCO patients and may have a role as a first-line treatment for anovulatory patients with PCOs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604826     DOI: 10.1177/147323000603400109

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  22 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

Review 2.  Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation.

Authors:  Mary Ellen Pavone; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2013-04-12       Impact factor: 5.958

Review 3.  Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women.

Authors:  Mohamed F M Mitwally; Robert F Casper
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Comparison of the Effect of Clomiphene- Estradiol Valerate vs Letrozole on Endometrial Thickness, Abortion and Pregnancy Rate in Infertile Women with Polycystic Ovarian Syndrome.

Authors:  Fariba Seyedoshohadaei; Laleh Tangestani; Farnaz Zandvakili; Naser Rashadmanesh
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 5.  Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Alexandra P Tsiami; Dimitrios G Goulis; Alexandros I Sotiriadis; Efstratios M Kolibianakis
Journal:  Hormones (Athens)       Date:  2021-05-25       Impact factor: 2.885

6.  A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.

Authors:  Kallol Kumar Roy; Jinee Baruah; Shilpa Singla; Jai Bhagwan Sharma; Neeta Singh; Sunesh Kumar Jain; Manu Goyal
Journal:  J Hum Reprod Sci       Date:  2012-01

7.  Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome.

Authors:  Ugochi C Okoroafor; Emily S Jungheim
Journal:  Patient Prefer Adherence       Date:  2012-05-24       Impact factor: 2.711

8.  Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate.

Authors:  Mohan S Kamath; Korula George
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

9.  Hormonal, follicular and endometrial dynamics in letrozole-treated versus natural cycles in patients undergoing controlled ovarian stimulation.

Authors:  Mohamed A Bedaiwy; Mahmoud A Abdelaleem; Mostafa Hussein; Noha Mousa; Lisa N Brunengraber; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

10.  Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Müllerian hormone levels.

Authors:  Stylianos Vagios; Caitlin R Sacha; Karissa C Hammer; Irene Dimitriadis; Kaitlyn E James; Charles L Bormann; Irene Souter
Journal:  J Assist Reprod Genet       Date:  2021-05-01       Impact factor: 3.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.